Wall St futures flat amid US-China trade jitters; bank earnings in focus
Investing.com -- Lifevantage Corporation (NASDAQ:LFVN) saw its shares fall 8% after market close on Thursday as the health and wellness company reported fourth quarter revenue that fell short of analyst expectations, despite posting earnings that slightly exceeded estimates.
The company reported fourth quarter revenue of $55.1 million, up 12.6% YoY but below the analyst consensus of $56.88 million. Adjusted earnings per share came in at $0.17, narrowly beating the analyst estimate of $0.16. The revenue miss overshadowed the company’s otherwise strong year-over-year growth and improved profitability.
"Fourth quarter results capped off a strong fiscal 2025 as we delivered revenue growth of approximately 13% to $55.1 million, expanded gross margin and increased earnings," said Steve Fife, President and CEO of LifeVantage.
Revenue in the Americas region increased 14.1% during the quarter, while Asia/Pacific & Europe revenue grew 7.6%, marking the first international growth in nearly three years. Excluding foreign currency fluctuations, fourth quarter revenue increased 11.6% overall.
Gross profit margin improved slightly to 79.9% compared to 79.5% in the same period last year. Adjusted EBITDA remained flat at $4.8 million compared to the prior year period.
For fiscal year 2026, Lifevantage provided guidance for revenue between $225 million and $240 million, in line with the analyst consensus of $231.3 million. The company expects adjusted earnings per share of $1.00 to $1.15, above the consensus estimate of $0.83.
The company maintained its strong balance sheet with $20.2 million in cash and no debt as of June 30, 2025. During fiscal 2025, Lifevantage repurchased 0.3 million shares for $3.1 million and declared a quarterly cash dividend of $0.045 per share.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.